It is administered as a once-weekly injection
The pattern that warrants deeper investigation is this: multiple body systems are affected, conventional labs have returned normal, standard treatments havent produced lasting improvement, and symptoms may worsen in specific environments (home, office, or car) and improve when youre away
KLOW is a four-peptide research blend combining GHK-Cu (50 mg), TB-500 (10 mg), BPC-157 (10 mg) and KPV (10 mg) 80 mg of total peptide per vial
Recent testing from the watchdog found a long list of counterfeit products contained no GLP-1 or any GLP-1 analogues at all, despite being labelled as such
The FDA labeling explicitly prohibits intramuscular or intravenous administration, as these routes were not studied in clinical trials
Today 53, 240253 (2018)